Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank9
Year-over-Year Change
Year-over-year gross profit growth rate
Percentile
P9
Near historical low
vs 3Y Ago
-28.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -345.99% |
| Q2 2025 | -141.82% |
| Q1 2025 | 152.82% |
| Q4 2024 | -244.60% |
| Q3 2024 | 325.78% |
| Q2 2024 | -61.82% |
| Q1 2024 | 72.46% |
| Q4 2023 | -16.09% |
| Q3 2023 | -28.30% |
| Q2 2023 | -14.59% |
| Q1 2023 | 79.91% |
| Q4 2022 | -11.88% |
| Q3 2022 | 12.29% |
| Q2 2022 | -101.18% |
| Q1 2022 | -359.14% |
| Q4 2021 | -7.54% |
| Q3 2021 | -2647.25% |
| Q2 2021 | 44.67% |
| Q1 2021 | 95.96% |
| Q4 2020 | -1180.58% |
| Q3 2020 | -115.54% |
| Q2 2020 | 1694.43% |
| Q1 2020 | 0.00% |
| Q4 2019 | 100.00% |
| Q3 2019 | 6.71% |
| Q2 2019 | -231.22% |
| Q1 2019 | 52.75% |
| Q4 2018 | 52.83% |
| Q3 2018 | -171.79% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |